REV 5901 is a competitive and orally active antagonist of leukotriene receptor, with a Ki of 0.7 µM. REV 5901 is also a 5-lipoxygenase inhibitor. REV 5901 can be used for the research of asthma in which leukotriene release be involved. REV 5901 can be used for the study of colon carcinoma[1][2][3].
Molekulargewicht:
335.44
Reinheit:
99.9
CAS Nummer:
[101910-24-1]
Formel:
C22H25NO2
Target-Kategorie:
Leukotriene Receptor,Lipoxygenase
Anwendungsbeschreibung:
MCE Product type: Reference compound
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten